Clinical trials
Completed Phase 3 trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4,054 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 37 |
| 2001 | 59 |
| 2002 | 71 |
| 2003 | 103 |
| 2004 | 143 |
| 2005 | 166 |
| 2006 | 213 |
| 2007 | 193 |
| 2008 | 221 |
| 2009 | 216 |
| 2010 | 229 |
| 2011 | 242 |
| 2012 | 239 |
| 2013 | 227 |
| 2014 | 204 |
| 2015 | 252 |
| 2016 | 183 |
| 2017 | 199 |
| 2018 | 203 |
| 2019 | 184 |
| 2020 | 118 |
| 2021 | 112 |
| 2022 | 69 |
| 2023 | 53 |
| 2024 | 23 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4,054 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 202 |
| Hoffmann-La Roche | 201 |
| Assistance Publique - Hôpitaux de Paris | 198 |
| Sanofi | 131 |
| GlaxoSmithKline | 113 |
| AstraZeneca | 110 |
| Bristol-Myers Squibb | 109 |
| Eli Lilly and Company | 105 |
| Pfizer | 100 |
| Boehringer Ingelheim | 88 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 132 |
| Diabetes Mellitus, Type 2 | 117 |
| Carcinoma, Non-Small-Cell Lung | 89 |
| Neoplasms | 83 |
| HIV Infections | 73 |
| Prostatic Neoplasms | 67 |
| Diabetes Mellitus | 65 |
| Pulmonary Disease, Chronic Obstructive | 63 |
| Arthritis, Rheumatoid | 60 |
| Asthma | 54 |
Trials
Showing 1 to 25 of 4,054. Each trial links to its page on Pharma Observatory.
3,954 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.